成人肝脏移植围术期麻醉管理专家共识

2020-05-30 中华医学会麻醉学分会 临床麻醉学杂志.2020,36(5):499-506.

肝脏移植是治疗终末期肝病的唯一确切的方法。目前我国每年实施的肝脏移植手术接近5000 例,临床应用已趋近成熟。肝脏移植手术操作复杂、耗时长、创伤大,除外科操作相关因素外,麻醉及围术期管理也对术后并发症

中文标题:

成人肝脏移植围术期麻醉管理专家共识

发布日期:

2020-05-30

简要介绍:

肝脏移植是治疗终末期肝病的唯一确切的方法。目前我国每年实施的肝脏移植手术接近5000 例,临床应用已趋近成熟。肝脏移植手术操作复杂、耗时长、创伤大,除外科操作相关因素外,麻醉及围术期管理也对术后并发症的产生及受者生存率有着重要影响。受者通常全身情况低下或并存其他疾病,抗、促凝系统的失衡及术中出血,无肝前期、无肝期、新肝期各具特点的病理生理及循环改变,上述因素均增加了肝脏移植围术期麻醉管理的难度。同时,由于供体器官的短缺导致一些扩大潜在供体库的技术持续兴起,以及等待移植的患者的年龄范围变得越来越宽,因此在这些复杂患者的围术期管理中麻醉科医师的作用显得愈发重要。

下载附件:

(因为版权问题,不支持下载)

评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=968805, encodeId=45ab968805d8, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20095471548, createdName=ms2000000895029841, createdTime=Thu May 27 06:38:51 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956503, encodeId=74859565039e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78f92247333, createdName=12159132m27(暂无昵称), createdTime=Tue Apr 13 11:14:40 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922062, encodeId=cdbb922062c2, content=刚好需要看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36465457931, createdName=ms7000000827997023, createdTime=Mon Feb 01 22:40:05 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895765, encodeId=a0b9895e654f, content=你这, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=mengmeng05116, createdTime=Fri Oct 30 23:14:15 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804793, encodeId=3eca804e93f2, content=新领域, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=094c5399432, createdName=北戴河, createdTime=Mon Jul 27 21:14:19 CST 2020, time=2020-07-27, status=1, ipAttribution=)]
    2021-05-27 ms2000000895029841

    学到了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=968805, encodeId=45ab968805d8, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20095471548, createdName=ms2000000895029841, createdTime=Thu May 27 06:38:51 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956503, encodeId=74859565039e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78f92247333, createdName=12159132m27(暂无昵称), createdTime=Tue Apr 13 11:14:40 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922062, encodeId=cdbb922062c2, content=刚好需要看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36465457931, createdName=ms7000000827997023, createdTime=Mon Feb 01 22:40:05 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895765, encodeId=a0b9895e654f, content=你这, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=mengmeng05116, createdTime=Fri Oct 30 23:14:15 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804793, encodeId=3eca804e93f2, content=新领域, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=094c5399432, createdName=北戴河, createdTime=Mon Jul 27 21:14:19 CST 2020, time=2020-07-27, status=1, ipAttribution=)]
    2021-04-13 12159132m27(暂无昵称)

    非常实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=968805, encodeId=45ab968805d8, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20095471548, createdName=ms2000000895029841, createdTime=Thu May 27 06:38:51 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956503, encodeId=74859565039e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78f92247333, createdName=12159132m27(暂无昵称), createdTime=Tue Apr 13 11:14:40 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922062, encodeId=cdbb922062c2, content=刚好需要看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36465457931, createdName=ms7000000827997023, createdTime=Mon Feb 01 22:40:05 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895765, encodeId=a0b9895e654f, content=你这, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=mengmeng05116, createdTime=Fri Oct 30 23:14:15 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804793, encodeId=3eca804e93f2, content=新领域, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=094c5399432, createdName=北戴河, createdTime=Mon Jul 27 21:14:19 CST 2020, time=2020-07-27, status=1, ipAttribution=)]
    2021-02-01 ms7000000827997023

    刚好需要看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=968805, encodeId=45ab968805d8, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20095471548, createdName=ms2000000895029841, createdTime=Thu May 27 06:38:51 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956503, encodeId=74859565039e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78f92247333, createdName=12159132m27(暂无昵称), createdTime=Tue Apr 13 11:14:40 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922062, encodeId=cdbb922062c2, content=刚好需要看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36465457931, createdName=ms7000000827997023, createdTime=Mon Feb 01 22:40:05 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895765, encodeId=a0b9895e654f, content=你这, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=mengmeng05116, createdTime=Fri Oct 30 23:14:15 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804793, encodeId=3eca804e93f2, content=新领域, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=094c5399432, createdName=北戴河, createdTime=Mon Jul 27 21:14:19 CST 2020, time=2020-07-27, status=1, ipAttribution=)]
    2020-10-30 mengmeng05116

    你这

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=968805, encodeId=45ab968805d8, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20095471548, createdName=ms2000000895029841, createdTime=Thu May 27 06:38:51 CST 2021, time=2021-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956503, encodeId=74859565039e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78f92247333, createdName=12159132m27(暂无昵称), createdTime=Tue Apr 13 11:14:40 CST 2021, time=2021-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922062, encodeId=cdbb922062c2, content=刚好需要看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36465457931, createdName=ms7000000827997023, createdTime=Mon Feb 01 22:40:05 CST 2021, time=2021-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895765, encodeId=a0b9895e654f, content=你这, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210524/55f15b58d91d45c09faf0272721b59d8/b8f36c2def38403ab9fdabaae56a939c.jpg, createdBy=f0935399328, createdName=mengmeng05116, createdTime=Fri Oct 30 23:14:15 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804793, encodeId=3eca804e93f2, content=新领域, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=094c5399432, createdName=北戴河, createdTime=Mon Jul 27 21:14:19 CST 2020, time=2020-07-27, status=1, ipAttribution=)]
    2020-07-27 北戴河

    新领域

    0

拓展阅读

肝脏移植生物样本采集与保藏技术专家共识

中国医药生物技术协会 · 2023-09-20

华西双供体肝脏移植专家共识

暂未更新 · 2024-03-20